178 related articles for article (PubMed ID: 37339496)
21. YBX1 expression and function in early hematopoiesis and leukemic cells.
Bhullar J; Sollars VE
Immunogenetics; 2011 Jun; 63(6):337-50. PubMed ID: 21369783
[TBL] [Abstract][Full Text] [Related]
22. Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia.
Yu H; Yin Y; Yi Y; Cheng Z; Kuang W; Li R; Zhong H; Cui Y; Yuan L; Gong F; Wang Z; Li H; Peng H; Zhang G
Cancer Commun (Lond); 2020 Oct; 40(10):501-517. PubMed ID: 32820611
[TBL] [Abstract][Full Text] [Related]
23. Resveratrol induces apoptosis and autophagy in T-cell acute lymphoblastic leukemia cells by inhibiting Akt/mTOR and activating p38-MAPK.
Ge J; Liu Y; Li Q; Guo X; Gu L; Ma ZG; Zhu YP
Biomed Environ Sci; 2013 Nov; 26(11):902-11. PubMed ID: 24331535
[TBL] [Abstract][Full Text] [Related]
24. Co-targeting CK2α and YBX1 suppresses tumor progression by coordinated inhibition of the PI3K/AKT signaling pathway.
Xu WF; Ma YC; Ma HS; Shi L; Mu H; Ou WB; Peng J; Li TT; Qin T; Zhou HM; Fu XQ; Li XH
Cell Cycle; 2019 Dec; 18(24):3472-3490. PubMed ID: 31713447
[TBL] [Abstract][Full Text] [Related]
25. Regulatory mechanism of interaction between Y-box-binding protein 1 and heterogenous nuclear ribonucleoprotein K in cell division cycle 25a signal pathway and lung cancer metastasis.
Fu L; Yang M; Ma Y
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):62-68. PubMed ID: 38279484
[TBL] [Abstract][Full Text] [Related]
26. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway.
Ling Z; Fang ZG; Wu JY; Liu JJ
Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686
[TBL] [Abstract][Full Text] [Related]
27. Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway.
Xu Y; Li J; Luo Y; Ma J; Huang P; Chen Y; He Z
Biochem Biophys Res Commun; 2023 Jan; 639():150-160. PubMed ID: 36495764
[TBL] [Abstract][Full Text] [Related]
28. The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia.
Mendes RD; Canté-Barrett K; Pieters R; Meijerink JP
Haematologica; 2016 Sep; 101(9):1010-7. PubMed ID: 27582570
[TBL] [Abstract][Full Text] [Related]
29. PI3Kγ/δ and NOTCH1 Cross-Regulate Pathways That Define the T-cell Acute Lymphoblastic Leukemia Disease Signature.
Efimenko E; Davé UP; Lebedeva IV; Shen Y; Sanchez-Quintero MJ; Diolaiti D; Kung A; Lannutti BJ; Chen J; Realubit R; Niatsetskaya Z; Ten V; Karan C; Chen X; Califano A; Diacovo TG
Mol Cancer Ther; 2017 Oct; 16(10):2069-2082. PubMed ID: 28716817
[TBL] [Abstract][Full Text] [Related]
30. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
[TBL] [Abstract][Full Text] [Related]
31. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway.
Abuduer M; A EZG
Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521
[TBL] [Abstract][Full Text] [Related]
32. RUNX1 is required for oncogenic
Choi A; Illendula A; Pulikkan JA; Roderick JE; Tesell J; Yu J; Hermance N; Zhu LJ; Castilla LH; Bushweller JH; Kelliher MA
Blood; 2017 Oct; 130(15):1722-1733. PubMed ID: 28790107
[TBL] [Abstract][Full Text] [Related]
33. CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia.
Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
Zhao X; Liu Y; Yu S
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA PRKCQ-AS1 promotes CRC cell proliferation and migration via modulating miR-1287-5p/YBX1 axis.
Cui G; Zhao H; Li L
J Cell Biochem; 2020 Oct; 121(10):4166-4175. PubMed ID: 32619070
[TBL] [Abstract][Full Text] [Related]
36. RP11-296E3.2 acts as an important molecular chaperone for YBX1 and promotes colorectal cancer proliferation and metastasis by activating STAT3.
Shi Q; He Y; He S; Li J; Xia J; Chen T; Huo L; Ling Y; Liu Q; Zang W; Wang Q; Tang C; Wang X
J Transl Med; 2023 Jun; 21(1):418. PubMed ID: 37370092
[TBL] [Abstract][Full Text] [Related]
37. NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia.
Guo D; Teng Q; Ji C
Leuk Lymphoma; 2011 Jul; 52(7):1200-10. PubMed ID: 21463127
[TBL] [Abstract][Full Text] [Related]
38. YBX1 Promotes MSC Osteogenic Differentiation by Activating the PI3K/AKT Pathway.
Chen J; Liu Z; Zhang H; Yang Y; Zeng H; Zhong R; Lai S; Liao H
Curr Stem Cell Res Ther; 2023; 18(4):513-521. PubMed ID: 35929633
[TBL] [Abstract][Full Text] [Related]
39. YBX1 regulated by Runx3-miR-148a-3p axis facilitates non-small-cell lung cancer progression.
Su H; Fan G; Huang J; Qiu X
Cell Signal; 2021 Sep; 85():110049. PubMed ID: 34082012
[TBL] [Abstract][Full Text] [Related]
40. YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.
Cui Q; Wang C; Liu S; Du R; Tian S; Chen R; Geng H; Subramanian S; Niu Y; Wang Y; Yue D
Cell Cycle; 2021 Nov; 20(22):2413-2427. PubMed ID: 34709966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
